Bristol-Myers to Pay $11 Billion to License Cancer Drug
Prior: P: 235.7
New: N: -
Prior: Prior: 235.7
New: New: -
-
Prior: Prior: 6.98
New: New: -
Prior: Prior: 49
New: New: -
Latest News
- Genesco Acknowledges 'More Pronounced' Tariff Impact, Stands By Guidance
- Apple Stock Is the Mag 7’s Biggest Loser. Today’s Downgrade Just Confirms It.
- Chart Industries and Flowserve to Merge in $19 Billion Deal. Industrials M&A Steams Ahead.
- Cardano Stages V-Shaped Recovery as Price Swings 4%
- Snowflake Is Rising After Its Investor Day. Why UBS Upgraded the Stock.
- Dollar Tree Warns of Tariff Hit Despite Earnings Beat. The Stock Sinks.